This is a StreetInsider.com Premium Only Page

Macrogenics (MGNX) – StreetInsider.com Reports

Apr 9, 2024 05:29 AM TD Cowen Upgrades MacroGenics (MGNX) to Buy, 'We Believe There Is Favorable Risk/Reward Heading Into The Efficacy Update By The End Of May'

Apr 4, 2024 04:40 AM Stifel on MacroGenics (MGNX): 'incrementally more positive', 'We remain buyers into the next “by May 31” clinical update'

Apr 3, 2024 04:42 PM After-hours movers: Alphabet, Levi, Paramount Global and more

Apr 3, 2024 04:30 PM Macrogenics (MGNX) Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures

Mar 11, 2024 06:51 AM MacroGenics (MGNX) PT Raised to $16 at H.C. Wainwright

Mar 11, 2024 02:04 AM MacroGenics (MGNX) PT Raised to $22 at JMP Securities

Mar 8, 2024 10:03 AM MacroGenics (MGNX) PT Raised to $29 at Stifel, 'still view valuation favorably here'

Mar 8, 2024 06:37 AM MacroGenics (MGNX) PT Raised to $24 at BMO Capital

Mar 7, 2024 04:14 PM Macrogenics (MGNX) Reports In-Line Q4 EPS

Mar 4, 2024 05:02 AM MacroGenics (MGNX) PT Raised to $24 at BTIG, 'Discussions with Physicians Increase our Confidence in Vobra Duo’s Profile'

Feb 29, 2024 03:42 AM MacroGenics (MGNX) PT Raised to $23 at Barclays

Feb 14, 2024 06:07 AM H.C. Wainwright Downgrades MacroGenics (MGNX) to Neutral

Jan 24, 2024 02:43 AM MacroGenics (MGNX) PT Raised to $16 at JMP Securities

Jan 2, 2024 06:36 AM MacroGenics (MGNX) PT Raised to $20 at Guggenheim

Dec 20, 2023 11:09 AM MacroGenics (MGNX) gains as Citi upgrades to Buy

Dec 19, 2023 05:30 PM After-hours movers: FedEx falls on weak results and lower guidance, drags down UPS

Dec 19, 2023 04:29 PM Citi Upgrades MacroGenics (MGNX) to Buy, 'Expanding ADC Pipeline Provides Good Set-Up for Shares in 2024'

Nov 13, 2023 06:41 AM MacroGenics (MGNX) PT Lowered to $12 at H.C. Wainwright

Nov 7, 2023 06:09 AM Guggenheim Upgrades MacroGenics (MGNX) to Buy

Nov 6, 2023 04:15 PM Macrogenics (MGNX) Files $300M Mixed Shelf

Nov 6, 2023 04:10 PM Macrogenics (MGNX) Tops Q3 EPS by 38c

Sep 5, 2023 07:01 AM Macrogenics (MGNX) Achieves $15M Milestone Related to Gilead’s (GILD) Nomination of a Bispecific Research Program

Aug 9, 2023 04:05 PM Macrogenics (MGNX) Tops Q2 EPS, Revenues Miss

May 25, 2023 07:06 AM MacroGenics (MGNX) PT Lowered to $7 at Citi

May 11, 2023 02:35 AM MacroGenics (MGNX) PT Raised to $10 at JMP Securities

May 9, 2023 04:29 PM Macrogenics (MGNX) Misses Q1 EPS by 110c

Mar 22, 2023 01:23 PM Macrogenics (MGNX) Earns $15M Milestone Payout Following FDA Approval of ZYNYZ

Mar 20, 2023 03:26 PM MacroGenics (MGNX) PT Raised to $12 at BTIG

Mar 20, 2023 06:39 AM MacroGenics (MGNX) PT Raised to $14 at H.C. Wainwright

Mar 17, 2023 06:21 AM Guggenheim Downgrades MacroGenics (MGNX) to Neutral

Mar 8, 2023 05:45 PM Macrogenics (MGNX) to sell TZIELD royalty interest for up to $200 million

Feb 14, 2023 05:46 AM Macrogenics (MGNX) Reports Prelim Results from Single Arm Study of Lorigerlimab

Jan 19, 2023 02:33 AM MacroGenics (MGNX) PT Lowered to $8 at JMP Securities

Jan 4, 2023 04:32 PM Macrogenics (MGNX) Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors

Nov 23, 2022 05:07 AM Citi Downgrades MacroGenics (MGNX) to Neutral

Nov 22, 2022 04:21 PM Guggenheim Upgrades MacroGenics (MGNX) to Buy

Nov 22, 2022 06:35 AM Cowen Downgrades MacroGenics (MGNX) to Market Perform

Nov 18, 2022 05:16 AM Macrogenics (MGNX) Earns $60M Milestone Payout Following FDA Approval of Teplizumab

Nov 14, 2022 05:02 AM UPDATE: BMO Capital Upgrades MacroGenics (MGNX) to Outperform

Nov 7, 2022 06:59 AM MacroGenics (MGNX) PT Raised to $12 at H.C. Wainwright

Nov 4, 2022 08:33 AM MacroGenics (MGNX) PT Raised to $15 at Stifel

Nov 4, 2022 07:07 AM MacroGenics (MGNX) PT Raised to $5.70 at BMO Capital

Oct 18, 2022 06:27 AM MacroGenics (MGNX) PT Raised to $11 at H.C. Wainwright

Oct 17, 2022 07:37 AM Macrogenics (MGNX) Climbs 40% Following Pact with Gilead Sciences (GILD)

Oct 17, 2022 07:32 AM Gilead Sciences (GILD) and MacroGenics (MGNX) Announce Oncology Collaboration to Develop Bispecific Antibodies

Sep 12, 2022 06:28 AM MacroGenics (MGNX) PT Lowered to $10 at H.C. Wainwright

Aug 26, 2022 10:22 AM MacroGenics (MGNX) PT Raised to $16 at Citi

Aug 9, 2022 08:13 AM MacroGenics (MGNX) PT Lowered to $14 at Stifel

Aug 9, 2022 05:33 AM MacroGenics (MGNX) PT Lowered to $8 at Barclays

Jul 18, 2022 05:32 AM SMBC Nikko Securities Downgrades MacroGenics (MGNX) to Neutral